DCTD Antibodies

Santa Cruz Biotechnology delivers a wide array of DCTD monoclonal antibodies for studying deoxycytidine triphosphate deaminase (DCTD). DCTD monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DCTD is a critical enzyme involved in the metabolism of nucleotides, specifically in the conversion of deoxycytidine triphosphate to deoxyuridine triphosphate, which is essential for DNA synthesis and repair. Its regulation is vital for maintaining cellular homeostasis and preventing the accumulation of toxic metabolites. Dysregulation of DCTD has been implicated in various diseases, including cancer, making it an important target for therapeutic intervention. DCTD monoclonal antibodies enable researchers to explore cellular pathways and molecular mechanisms involved in nucleotide metabolism. Understanding DCTD expression patterns and interactions provides crucial information about cellular processes and disease progression. Research with DCTD monoclonal antibodies from Santa Cruz Biotechnology continues to advance scientific knowledge in cancer research and therapeutic development.